Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2006-08-12 19:06:36 UTC |
---|
Update Date | 2023-02-21 17:16:36 UTC |
---|
HMDB ID | HMDB0003338 |
---|
Secondary Accession Numbers | - HMDB0060880
- HMDB03338
- HMDB60880
|
---|
Metabolite Identification |
---|
Common Name | Hydroxylamine |
---|
Description | Hydroxylamine is a reactive chemical with formula NH2OH. It can be considered a hybrid of ammonia and water due to parallels it shares with each. At room temperature pure NH2OH is ordinarily a white, unstable crystalline, hygroscopic compound; however it is almost always encountered as an aqueous solution. A colorless inorganic compound (HONH2) used in organic synthesis and as a reducing agent, due to its ability to donate nitric oxide. Hydroxylamine may explode on heating. It is an irritant to the respiratory tract, skin, eyes, and other mucous membranes. It may be absorbed through the skin, is harmful if swallowed, and is a possible mutagen. NH2OH is an intermediate in the biological nitrification. The oxidation of NH3 is mediated by HAO (hydroxylamine oxidoreductase). |
---|
Structure | InChI=1S/H3NO/c1-2/h2H,1H2 |
---|
Synonyms | Value | Source |
---|
[NH2OH] | ChEBI | H2NHO | ChEBI | HYDROXYAMINE | ChEBI | Hydroxylamin | ChEBI | Oxyammonia | ChEBI | NH2OH | Kegg | Hydroxylamine hydrochloride | MeSH | Hydroxylammonium chloride | MeSH | (1) Hydroxylamine | HMDB | Dihydridohydroxidonitrogen | HMDB | Hydroxyamine hydrochloride | HMDB | Hydroxylamine chloride | HMDB | Hydroxylamine-1-hydrochloride | HMDB | Nitroxide | HMDB | Oxammonium | HMDB | Oxammonium hydrochloride | HMDB | Chloride, hydroxylammonium | MeSH, HMDB | Hydrochloride, hydroxylamine | MeSH, HMDB |
|
---|
Chemical Formula | H3NO |
---|
Average Molecular Weight | 33.0299 |
---|
Monoisotopic Molecular Weight | 33.021463723 |
---|
IUPAC Name | hydroxylamine |
---|
Traditional Name | hydroxylamine |
---|
CAS Registry Number | 7803-49-8 |
---|
SMILES | NO |
---|
InChI Identifier | InChI=1S/H3NO/c1-2/h2H,1H2 |
---|
InChI Key | AVXURJPOCDRRFD-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of inorganic compounds known as homogeneous other non-metal compounds. These are inorganic non-metallic compounds in which the largest atom belongs to the class of 'other non-metals'. |
---|
Kingdom | Inorganic compounds |
---|
Super Class | Homogeneous non-metal compounds |
---|
Class | Homogeneous other non-metal compounds |
---|
Sub Class | Not Available |
---|
Direct Parent | Homogeneous other non-metal compounds |
---|
Alternative Parents | Not Available |
---|
Substituents | - Homogeneous other non metal
|
---|
Molecular Framework | Not Available |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 33 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 111.698 | 30932474 | DeepCCS | [M-H]- | 109.903 | 30932474 | DeepCCS | [M-2H]- | 145.099 | 30932474 | DeepCCS | [M+Na]+ | 118.564 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
Hydroxylamine | NO | 1330.5 | Standard polar | 33892256 | Hydroxylamine | NO | 569.5 | Standard non polar | 33892256 | Hydroxylamine | NO | 590.6 | Semi standard non polar | 33892256 |
DerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Hydroxylamine,1TMS,isomer #1 | C[Si](C)(C)NO | 725.9 | Semi standard non polar | 33892256 | Hydroxylamine,1TMS,isomer #1 | C[Si](C)(C)NO | 763.8 | Standard non polar | 33892256 | Hydroxylamine,1TMS,isomer #1 | C[Si](C)(C)NO | 1108.8 | Standard polar | 33892256 | Hydroxylamine,2TMS,isomer #1 | C[Si](C)(C)N(O)[Si](C)(C)C | 927.3 | Semi standard non polar | 33892256 | Hydroxylamine,2TMS,isomer #1 | C[Si](C)(C)N(O)[Si](C)(C)C | 923.4 | Standard non polar | 33892256 | Hydroxylamine,2TMS,isomer #1 | C[Si](C)(C)N(O)[Si](C)(C)C | 1089.0 | Standard polar | 33892256 | Hydroxylamine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NO | 963.0 | Semi standard non polar | 33892256 | Hydroxylamine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NO | 944.6 | Standard non polar | 33892256 | Hydroxylamine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NO | 1213.6 | Standard polar | 33892256 | Hydroxylamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(O)[Si](C)(C)C(C)(C)C | 1329.1 | Semi standard non polar | 33892256 | Hydroxylamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(O)[Si](C)(C)C(C)(C)C | 1298.2 | Standard non polar | 33892256 | Hydroxylamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(O)[Si](C)(C)C(C)(C)C | 1307.6 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Hydroxylamine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (3 TMS) | splash10-00di-9800000000-40500c2ce42330f68e23 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Hydroxylamine GC-MS (3 TMS) | splash10-001j-1900000000-380d2510f339c8852cae | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Hydroxylamine GC-EI-TOF (Non-derivatized) | splash10-00di-9800000000-40500c2ce42330f68e23 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Hydroxylamine GC-MS (Non-derivatized) | splash10-001j-1900000000-380d2510f339c8852cae | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Hydroxylamine GC-EI-TOF (Non-derivatized) | splash10-00m1-1900000000-7c1a1a9c2955e5f4d75e | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxylamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-9000000000-6a1320306a7bbc43c258 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxylamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxylamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Hydroxylamine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-001i-9000000000-17862dd274dc5ae95e9b | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Hydroxylamine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-001i-9000000000-c7d671f97d82bbe3e458 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Hydroxylamine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-001i-9000000000-36b50bedfc3b86b95fdf | 2012-07-25 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 10V, Positive-QTOF | splash10-001i-9000000000-190eddac91b76eed9065 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 20V, Positive-QTOF | splash10-001i-9000000000-190eddac91b76eed9065 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 40V, Positive-QTOF | splash10-001i-9000000000-190eddac91b76eed9065 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 10V, Negative-QTOF | splash10-001i-9000000000-20928e005423160892f3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 20V, Negative-QTOF | splash10-001i-9000000000-20928e005423160892f3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 40V, Negative-QTOF | splash10-001i-9000000000-20928e005423160892f3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 10V, Positive-QTOF | splash10-001i-9000000000-190eddac91b76eed9065 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 20V, Positive-QTOF | splash10-001i-9000000000-190eddac91b76eed9065 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 40V, Positive-QTOF | splash10-001i-9000000000-190eddac91b76eed9065 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 10V, Negative-QTOF | splash10-001i-9000000000-6c136ec6f9ff4bb55445 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 20V, Negative-QTOF | splash10-001i-9000000000-6c136ec6f9ff4bb55445 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylamine 40V, Negative-QTOF | splash10-001i-9000000000-6c136ec6f9ff4bb55445 | 2021-09-23 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm (predicted from logP)
|
---|
Biospecimen Locations | |
---|
Tissue Locations | - Epidermis
- Fibroblasts
- Kidney
- Liver
- Spleen
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Bladder cancer | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB007499 |
---|
KNApSAcK ID | C00053330 |
---|
Chemspider ID | 766 |
---|
KEGG Compound ID | C00192 |
---|
BioCyc ID | HYDROXYLAMINE |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Hydroxylamine |
---|
METLIN ID | 6894 |
---|
PubChem Compound | 787 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 15429 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Lin J, Cashman JR: Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime. Chem Res Toxicol. 1997 Aug;10(8):842-52. [PubMed:9282832 ]
- Yang X, Arosio P, Chasteen ND: Molecular diffusion into ferritin: pathways, temperature dependence, incubation time, and concentration effects. Biophys J. 2000 Apr;78(4):2049-59. [PubMed:10733983 ]
- Atamna H, Robinson C, Ingersoll R, Elliott H, Ames BN: N-t-Butyl hydroxylamine is an antioxidant that reverses age-related changes in mitochondria in vivo and in vitro. FASEB J. 2001 Oct;15(12):2196-204. [PubMed:11641246 ]
- Cribb AE, Spielberg SP: Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther. 1992 May;51(5):522-6. [PubMed:1587066 ]
- Alonso A, Meirelles NC, Tabak M: Stratum corneum intercellular lipid as compared to erythrocyte ghosts: an ESR study of thermotropic behavior and nitroxide reduction. Electron Spin Resonance. Physiol Chem Phys Med NMR. 1995;27(1):63-72. [PubMed:7617746 ]
- Fuchs J, Freisleben HJ, Podda M, Zimmer G, Milbradt R, Packer L: Nitroxide radical biostability in skin. Free Radic Biol Med. 1993 Oct;15(4):415-23. [PubMed:8225023 ]
- Kurian JR, Bajad SU, Miller JL, Chin NA, Trepanier LA: NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. J Pharmacol Exp Ther. 2004 Dec;311(3):1171-8. Epub 2004 Aug 9. [PubMed:15302896 ]
- Coleman MD, Jacobus DP: Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma. Biochem Pharmacol. 1993 Oct 19;46(8):1363-8. [PubMed:8240384 ]
- Peng SX, Strojnowski MJ, Hu JK, Smith BJ, Eichhold TH, Wehmeyer KR, Pikul S, Almstead NG: Gas chromatographic-mass spectrometric analysis of hydroxylamine for monitoring the metabolic hydrolysis of metalloprotease inhibitors in rat and human liver microsomes. J Chromatogr B Biomed Sci Appl. 1999 Mar 5;724(1):181-7. [PubMed:10202971 ]
- Forsyth NR, Evans AP, Shay JW, Wright WE: Developmental differences in the immortalization of lung fibroblasts by telomerase. Aging Cell. 2003 Oct;2(5):235-43. [PubMed:14570231 ]
- Goda R, Nagai D, Akiyama Y, Nishikawa K, Ikemoto I, Aizawa Y, Nagata K, Yamazoe Y: Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients. Drug Metab Dispos. 2006 May;34(5):828-35. Epub 2006 Feb 28. [PubMed:16507648 ]
- Winter HR, Unadkat JD: Identification of cytochrome P450 and arylamine N-acetyltransferase isoforms involved in sulfadiazine metabolism. Drug Metab Dispos. 2005 Jul;33(7):969-76. Epub 2005 Apr 20. [PubMed:15843491 ]
- Coleman MD: Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol. 1993 Nov;129(5):507-13. [PubMed:8251346 ]
|
---|